Smart Immune

Paris, France

Smart Immune is a biotech company that helps fight against cancer and infection by providing a thymus-empowered T-cell therapy platform.

$5.0M raised

Apr 2023

Grant

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Smart Immune raised?

Smart Immune has raised $5.0M in total funding. The most recent round was Grant. The last funding was announced in April 2023.

Who are Smart Immune's investors?

Smart Immune's investors include Bill & Melinda Gates Foundation, European Innovation Council, Sebastian Lombardo.

Where is Smart Immune headquartered?

Smart Immune is headquartered in Paris, France.

What does Smart Immune do?

Smart Immune is a biotech company that helps fight against cancer and infection by providing a thymus-empowered T-cell therapy platform.

What stage is Smart Immune at?

Smart Immune is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 16, 2023.

MLA

"Smart Immune — Funding & Investors." VCBacked, April 16, 2023, https://www.vcbacked.co/company/smart-immune. Accessed July 3, 2026.

APA

VCBacked. (2023). Smart Immune — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/smart-immune

Wikipedia (cite web)

{{cite web |title=Smart Immune — Funding & Investors |url=https://www.vcbacked.co/company/smart-immune |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 16, 2023.